FOXP1 and neoplasm: This study delineates a previously unrecognized axis of radiation-induced immune evasion in ESCC, revealing that radiotherapy triggers tumor-derived EVs to deliver lncRNA DYNLL1-AS1 that reprograms macrophage PD-L1 expression via SEC22B/FOXP1 signaling.